PCSK9 inhibitors in clinical practice: Expectations and reality

Authors

Keywords

PCSK9 inhibitors, LDL-cholesterol, Familial hypercholesterolaemia, Statin intolerance, Evolocumab, Alirocumab

Journal

ATHEROSCLEROSIS

Volume 270, Issue -, Pages 187-188

Publisher

Elsevier BV

Online

2018-01-31

DOI

10.1016/j.atherosclerosis.2018.01.001

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More